Physician interviews reveal increasing use of systemic therapy for Ia/mUC
Emerging therapies act by neprilysin inhibition and heart rate reduction
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy